Skip to content
Home/Companies/Pharma/Purpose Pharma

Purpose Pharma

Pharma·Sweden·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Purpose Pharma?

Purpose Pharma is a Swedish Pharma company, currently owned by Eir Ventures since 2024.

Hand-verified · updated 2026-08-17

Open JSON · CC-BY
Eir Ventures
Investor
Eir Ventures
Eir Ventures I · 2020 · Life Sciences VC

Key facts

HQSweden
SectorPharma
StatusActive

More from Eir Ventures I

Other portfolio companies in the same fund.

Moleculent
Active
BiotechSweden· 2024
Dania Tx
Active
BiotechDenmark· 2023
GutCRINE
Active
BiotechDenmark· 2023
RAPP
Active
HealthTechSweden· 2023
Scenic Biotech
Scenic Biotech
Active
BiotechNetherlands· 2023
Attgeno
Active
BiotechSweden· 2022

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Purpose Pharma?

Purpose Pharma is currently owned by Eir Ventures, through Eir Ventures I, since 2024.

When did Eir Ventures acquire Purpose Pharma?

Eir Ventures acquired Purpose Pharma in 2024.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue